Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2007 / Cilt: 33 - Sayı: 1

Correlation between the pathologic features of radıcal retropubic prostatectomy specimens and free/total PSA ratios

Radikal retropubik prostatektomi sonrası elde edilen prostat dokusuna ait patolojik özelikler ile ameliyat öncesi serbest/total prostat spesifik antijen oranı arasındaki ilişki

Pages
13–17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies with larger number of patients are needed to confirm these results.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: There are many reports about the prognostic significance of the pathologic features of radical retropubic prostatectomy specimens in patients with localized prostate cancer.
📊
Key Findings & Data:Materials and Methods: We retrospectively evaluated the data of 109 radical retropubic prostatectomy patients.
💡
Conclusion & Impact:Further studies with larger number of patients are needed to confirm these results.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Ürolojik cerrahi prosedürler · Prostatektomi · Patoloji

Abstract

Introduction: There are many reports about the prognostic significance of the pathologic features of radical retropubic prostatectomy specimens in patients with localized prostate cancer. In our study we evaluated the relation between the preoperative free/total prostate specific antigen ratio (f/t PSA) and pathologic features of radical retropubic prostatectomy specimens. Materials and Methods: We retrospectively evaluated the data of 109 radical retropubic prostatectomy patients. Patients were divided into 3 groups according to their PSA levels (<10, 10-15, >15 ng/dl) and f/t PSA ratio (<0.10, 0.10-0.20, >0.20). We investigated the distribution of the patients to the groups according to pathologic features of radical retropubic prostatectomy specimens such as surgical margin positivity (SMP), extracapsular extension (ECE), seminal vesicle involvement (SVI), perineural invasion and pathologic stage. Results: Mean patient age was 61.6±5.9 years, mean PSA level was 10.6±6.7 ng /ml and mean f/t PSA ratio was 0.16±0.13. There was not any statistically significant difference between the PSA groups regarding the pathologic features of radical retropubic prostatectomy specimens (p>0.05). Pathological stage, SMP, ECE and SVI were higher in f/t PSA ratio <0.10 (p<0.05). Conclusion: We think that preoperative f/t PSA ratio could be a useful determinant for estimating the prognosis of radical retropubic prostatectomy patients according to pathological features of surgical specimens. Further studies with larger number of patients are needed to confirm these results.

Özet

Organa sınırlı prostat kanseri nedeniyle radikal retropubik prostatektomi uygulanan hastalarda, patolojik örneklerde bildirilen özelliklerin prognostik önemi üzerine birçok çalışma rapor edilmiştir. Bu çalışmada ameliyat öncesi dönemdeki serbest/total prostat spesifik antijen oranının (s/t PSA) bu özelliklerle olan ilişkisi değerlendirildi. Radikal retropubik prostatektomi uygulanmış 109 hastaya ait veriler geriye dönük olarak değerlendirildi. Hastalar ameliyat öncesi serum total PSA (tPSA) düzeylerine ( 15 ng/ml) ve s/tPSA oranlarına (%10, %10-20, >%20) göre gruplara ayrıldı. Gruplarda yer alan hastaların cerrahi spesimende bildirilen cerrahi sınır pozitifliği (CSP), ekstrakapsüler yayılım (EKY), seminal vezikül tutulumu (SVT), perinöral invazyon varlığı ve patolojik evrelerine göre dağılımları incelendi. Hastaların ortalama yaşı, t-PSA düzeyi ve s/t PSA oranı sırasıyla, 61,6±5,9, 10,6±6,7ng/ml ve %0,16±0,13 idi. t-PSA düzeylerine göre gruplar arasında spesimenin patolojik özellikleri yönünden fark yoktu (p>0.05). s/t PSA oranı <%10 olan grupta patolojik evre, CSP, EKY ve SVT oranları diğer gruplardan daha yüksekti (p<0.05). Radikal retropubik prostatektomi uygulanacak yerleşimli prostat kanserli hastaların patolojik spesimendeki özelliklere göre hastalık seyri durumunu belirlemede, ameliyat öncesi s/t PSA oranının faydalı bir ölçüt olabileceğini düşünmekteyiz. Bu sonuçların daha geniş sayıda hasta içeren çalışmalarla desteklenmesi gerekmektedir.

🔖

Cite This Article

ÖZTÜRK, B., ÖZDEN, C., KOŞAN, M., YARİŞ, M., ADSAN, Ö., MEMİŞ, A. (2007). Correlation between the pathologic features of radıcal retropubic prostatectomy specimens and free/total PSA ratios. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 33 - Sayı: 1, 13–17. https://ajindex.com/articles/328319

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Boring CC, Squires TS, Tong T, et al: Cancer statistics, 1994. CA Cancer J Clin. 44: 7-26, 1994
  2. Zincke H, Oesterling JE, Blute ML, et al: Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. J Urol. 152: 1850-1857, 1994
  3. Partin AW, Pound CR, Clemens JQ, et al: Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. Urol Clin North Am. 20: 713-725, 1993
  4. Partin AW, Kattan MW, Subong EN, et al: Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 277:1445-1451, 1997
  5. Partin AW, Yoo J, Carter HB, et al: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol. 150: 110-114, 1993
  6. Collins GN, Alexandrou K, Wynn-Davies A, et al: Free prostate-specific antigen 'in the field': A useful adjunct to standard clinical practice. BJU Int. 83: 1000-1002, 1999
  7. Morote J, Encabo G, de Torres IM: Use of percent free prostate-specific antigen as a predictor of the pathological features of clinically localized prostate cancer. Eur Urol. 38: 225-229, 2000
  8. Okegawa T, Noda H, Ohta M, et al: Use of various combinations of free, complexed and total prostate-specific antigen levels as predictors of the pathologic stage of prostate cancer. Int J Urol. 8: 438-443, 2001
  9. Erdem E, Atsu N, Akbal C, et al: The free-to-total serum prostatic specific antigen ratio as a predictor of the pathological features of prostate cancer. Int Urol Nephrol. 34: 519-523, 2002
  10. Aslan G, Irer B, Kefi A, et al: The value of PSA, freeto- total PSA ratio and PSA density in the prediction of pathologic stage for clinically localized prostate cancer. Int Urol Nephrol. 37: 511-514, 2005
  11. Ravery V, Chastang C, Toublanc M, et al: Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer. Eur Urol. 37: 449-455, 2000
  12. Cornud F, Belin X, Flam T, et al: Local staging of prostate cancer by endorectal MRI using fast spin-echo sequences: prospective correlation with pathological findings after radical prostatectomy. Br J Urol. 77: 843-850, 1996
  13. McSherry SA, Levy F, Schiebler ML, et al: Preoperative prediction of pathological tumor volume and stage in clinically locali